The human gene encoding the 5-Hydroxytryptamine receptor 2B (HTR2B), also known as the serotonin receptor 2B, turn out to be the most discriminating among the class II genes in order to identify UM patients at high risk of evolving toward the liver metastatic disease [4,5]. This evidence concerns the gene HTR2B and medical procedure.